![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 13, 2014 11:16:02 AM
PharmaPods are made to order, and each is configured differently based on client requirements. Under standard accounting rules, revenue is not recognized until the product ships. Therefore there will be $0 revenue from this order in the financial statements for Q4 2013, and probably $0 for Q1 2014 unless they are able to complete the production of one or more pods by the end of March. In any case, the order is spread out over 2 years and the actual value of the contract is unknown.
Anyone making wild prediction about revenue for these two quarters should call the company and ask them about time to deliver after a contract is in place, and what their current production throughput capability is.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM